1.
Rev Assoc Med Bras (1992)
; 66(9): 1169-1171, 2020 09.
Article
in English
| MEDLINE
| ID: mdl-33027439
Subject(s)
Coronavirus Infections/therapy , Ethanol/therapeutic use , Pneumonia, Viral/therapy , Betacoronavirus , COVID-19 , Humans , Pandemics , SARS-CoV-2
2.
Rev. Assoc. Med. Bras. (1992)
; 66(9): 1169-1171, Sept. 2020. tab, graf
Article
in English
| Sec. Est. Saúde SP, LILACS
| ID: biblio-1136374
3.
Drug Discov Today
; 25(6): 956-958, 2020 06.
Article
in English
| MEDLINE
| ID: mdl-32325124
ABSTRACT
This article examines three aspects of antivirals, such as hydroxychloroquine, chloroquine, and remdesvir, as they might relate to the treatment of a viral infection such as COVID-19: (i) the use of vaporization for the delivery of antivirals, with the bulk constituents having mild antiviral efficacy; (ii) the application of a marine natural product extract as opposed to a single molecule as an antiviral agent; and (iii) a counter intuitive approach to formulation that is, in part, based on delivering multiple species that fall into three categories: building blocks for the virus to accelerate replication; an energy source for the infected cell to boost its immune response; and the species that antagonize or provide toxicity to the virus.